Mouse, Rat, Human
A 16 amino acid synthetic peptide from near the center of Human LIMP2 (AAH21892).
- Human skeletal muscle tissue and lysate.
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Preservative: 0.02% Sodium Azide
Concentration information loading...
Immunogen affinity purified
Our Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
||Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 54 kDa.
||Use at an assay dependent concentration.
Acts as a lysosomal receptor for glucosylceramidase (GBA) targeting.
(Microbial infection) Acts as a receptor for enterovirus 71.
Epilepsy, progressive myoclonic 4, with or without renal failure
Genetic variants in SCARB2 can act as modifier of the phenotypic expression and severity of Gaucher disease.
Belongs to the CD36 family.
Information by UniProt
- 85 kDa lysosomal membrane sialoglycoprotein antibody
- 85 kDa lysosomal sialoglycoprotein scavenger receptor class B member 2 antibody
- AMRF antibody
Western blot - Anti-LIMPII antibody (ab106519)
Western blot analysis of LIMP2 in mouse liver tissue lysate with LIMP2 antibody at 1 µg/mL in (A) the absence and (B) presence of blocking peptide.
Western blot - LIMPII antibody (ab106519)
All lanes : Anti-LIMPII antibody (ab106519) at 1 µg/ml
Lane 1 : Human skeletal muscle tissue lysate
Lane 2 : Human skeletal muscle tissue lysate with blocking peptide
Lysates/proteins at 15 µg per lane.
Predicted band size: 54 kDa
Despite its predicted molecular weight, LIMPII runs at approximately 80 – 85 kDa in SDS-PAGE.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"